Super Bowl Victory ...
Services: Diversified Services
Gen-Probe Inc. (GPRO: NASDAQ)
$68.41 0.32 | 0.47%
02/08/12 - 04:00 PM ET
282.70K / 346.10K
Vol / Avg. Vol:68.20 / 68.09
Open / Prev. Close:66.75 - 68.49
Today's Range:53.92 - 86.96
52 Wk Range:15.71%
Performance YTD:TheStreet Rating:
Portfolios with GPRO
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ProPowerShares Buyback Achieve...
- ProMorgan Stanley Inst. Small ...
- UserPART 6 JPMorgan 28th Annual...
- ContributorTechnical Set Ups for the W...
- Usermim
- UserPART 6 JPMorgan 27th Annual...
- UserSteve Fox Portfolio 1
- ProAngelo Gordon & Co
- UserInsider Purchases and Buyba...
Latest GPRO Headlines from TheStreet
- Stock Upgrades: Seagate 02.02.12 | 12:02 pm
- Gen-Probe Inc. Stock Upgraded (GPRO) 02.02.12 | 06:02 am
- Analysts' Actions: GRPN, VRUS, MU, CVC 12.19.11 | 09:12 am
- Gen-Probe Inc. Stock Downgraded (GPRO) 11.04.11 | 07:11 am
- Gen-Probe's CEO Discusses Q3 2011 Results - Earnings Call Transcript 11.02.11 | 08:11 pm
- Gen-Probe's CEO Discusses Q2 2011 Results - Earnings Call Transcript 07.28.11 | 09:07 pm
- BofA, VMWare: Analysts' New Ratings 07.20.11 | 10:07 am
- 10 Stocks to Watch: Temple-Inland, Pep Boys 06.07.11 | 08:06 am
- Oracle, Gen-Probe: Analysts' New Ratings 05.26.11 | 09:05 am
- Gen-Probe Rises On Unusually High Volume (GPRO) 05.18.11 | 03:05 pm
Press Releases for GPRO
- Gen-Probe Announces Webcast Of Fourth Quarter And Full Year 2011 Earnings Conference Call - PR Newswire 01.27.12 | 08:01 am
- New Products, Solid Base Businesses Expected To Drive Double-Digit Revenue Growth For Gen-Probe In 2012 - PR Newswire 01.09.12 | 08:01 am
- Gen-Probe To Webcast Presentation At The Oppenheimer 22nd Annual Healthcare Conference - PR Newswire 12.09.11 | 04:12 pm
- Hank Nordhoff To Retire From Gen-Probe - PR Newswire 11.15.11 | 04:11 pm
- Gen-Probe To Webcast Three Upcoming Investor Presentations - PR Newswire 11.11.11 | 04:11 pm
- FDA Approves Gen-Probe's APTIMA® HPV Assay, New Molecular Test To Detect Virus That Causes Cervical Cancer - PR Newswire 10.31.11 | 07:10 am
- Gen-Probe Announces Webcast Of Third Quarter 2011 Earnings Conference Call - PR Newswire 10.11.11 | 07:10 pm
- Gen-Probe To Webcast Three Upcoming Investor Presentations - PR Newswire 08.31.11 | 04:08 pm
- Gen-Probe To Webcast Two Upcoming Investor Presentations - PR Newswire 07.29.11 | 08:07 am
- Roka Bioscience Completes $20 Million Series C Financing - PR Newswire 07.28.11 | 01:07 pm
Partner Headlines for GPRO
- Reaffirming Gen-Probe at Neutral - Analyst Blog - Zacks 11.10.11 | 06:11 pm
- FDA Clears Gen-Probe's HPV Test - Analyst Blog - Zacks 11.02.11 | 06:11 pm
- Piper Jaffray Maintains Overweight Rating on Gen-Probe - Benzinga 10.11.11 | 09:10 am
- U.S. FDA advisory meetings through Nov. 16 - Reuters 09.19.11 | 01:09 pm
- 9 Of Richard F. Aster's Q2 Stock Holdings - Seeking Alpha 09.06.11 | 09:09 am
- Novartis No Longer Interested in Pursuing Gen-Probe Acquisition -WSJ - Benzinga 07.19.11 | 01:07 pm
- Taking On Healthcare Costs via the Private Sector - Seeking Alpha 06.20.11 | 07:06 am
- Company News for June 07, 2011 - Corporate Summary - Zacks 06.07.11 | 10:06 am
- UPDATE 1-Gen-Probe shares fall after report one bidder left - Reuters 06.06.11 | 12:06 pm
- Company News for May 27, 2011 - Corporate Summary - Zacks 05.27.11 | 10:05 am
